Save time and get answers to complex questions with AI chat
The expiration date of the key patent for guselkumab?Patent term adjustment semaglutida?What's the advised delay for milk post lipitor?Guselkumab patent expiration?Alogliptin benz cost?
See the DrugPatentWatch profile for Janumet
Janumet is an antidiabetic medicine that combines two drugs: metformin and sitagliptin. [1] - Metformin is a biguanide (it lowers glucose production in the liver and improves insulin sensitivity). [1] - Sitagliptin is a DPP-4 inhibitor (it helps increase incretin hormones, which increase insulin release and decrease glucagon). [1]
Because it includes both a biguanide and a DPP-4 inhibitor, Janumet is used to treat type 2 diabetes to improve blood sugar control. [1]
Janumet is essentially metformin + a DPP-4 inhibitor, so it’s typically positioned when metformin alone isn’t enough. The sitagliptin component adds an incretin-based mechanism on top of metformin’s effects. [1]
Other diabetes treatments may also use metformin or DPP-4 inhibitors, but Janumet is specifically the combination of those two drug classes in one product. [1]
1 Drugs.com — Janumet (metformin/sitagliptin)
Other Questions About Janumet :